T cell density and location can influence the prognosis of ovarian cancer

Pathology and Oncology Research

Volumn 16, Issue 3, 2010, Pages 361-370

  Al Attar, Ahmad ^a   Shehata, Mohamed ^a   Durrant, Lindy ^b   Moseley, Paul ^a   Deen, Suha ^a   Chan, Stephen ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Intra tumoural T cells; Ovarian cancer; Prognosis; Stromal T cells

Indexed keywords

CARBOPLATIN; CD3 ANTIGEN; PLATINUM COMPLEX;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PREDICTION; PROGNOSIS; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; T-LYMPHOCYTES; TISSUE ARRAY ANALYSIS;

EID: 77956873287     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9230-5     Document Type: Article

References (40)

1. CRUK (2009) UK Ovarian Cancer statistics [cited 2009 20/05/2009]; Available from:
2. MR Hussein HI Hassan 2006 Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations J Clin Pathol 59 9 972 977 1:STN:280:DC%2BD28rhtFKmtA%3D%3D 10.1136/jcp.2005.031252 16935972
3. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian, et al. 2005 Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 51 18538 18543 1:CAS:528:DC%2BD28Xpt1Om 10.1073/pnas.0509182102 16344461
4. CA Shah KH Allison RL Garcia HJ Gray BA Goff EM Swisher 2008 Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer Gynecol Oncol 109 2 215 219 1:CAS:528:DC%2BD1cXlsFOjsLk%3D 10.1016/j.ygyno.2008. 01.010 18314181
5. L Zhang JR Conejo-Garcia D Katsaros PA Gimotty M Massobrio G Regnani, et al. 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 3 203 213 1:CAS:528:DC%2BD3sXksVehug%3D%3D 10.1056/NEJMoa020177 12529460
6. H Echchakir I Vergnon G Dorothee D Grunenwald S Chouaib F Mami-Chouaib 2000 Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung Int Immunol 12 4 537 546 1:CAS:528:DC%2BD3cXisl2hs7k%3D 10.1093/intimm/12.4.537 10744655
7. E Halapi Y Yamamoto C Juhlin M Jeddi-Tehrani J Grunewald R Andersson, et al. 1993 Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas Cancer Immunol Immunother 36 3 191 197 1:CAS:528:DyaK3sXitlahs7w%3D 10.1007/BF01741091 8439980
8. F Balkwill 2009 Tumour necrosis factor and cancer Nat Rev 9 5 361 371 1:CAS:528:DC%2BD1MXjvF2gtLk%3D
9. T Hagemann F Balkwill T Lawrence 2007 Inflammation and cancer: a double-edged sword Canc Cell 12 4 300 301 1:CAS:528:DC%2BD2sXht1ais7zM 10.1016/j.ccr.2007.10.005
10. H Kulbe R Thompson JL Wilson S Robinson T Hagemann R Fatah, et al. 2007 The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells Cancer Res 67 2 585 592 1:CAS:528:DC%2BD2sXmtVKksQ%3D%3D 10.1158/0008-5472.CAN-06-2941 17234767
11. GP Dunn AT Bruce H Ikeda LJ Old RD Schreiber 2002 Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 11 991 998 1:CAS:528:DC%2BD38Xot1Chs70%3D 10.1038/ni1102-991 12407406
12. Dougan M, Dranoff G (2009) The immune response to tumors. Current protocols in immunology. In: Coligan JE et al (eds) Chapter 20:Unit 20 11.
13. TJ Stewart SI Abrams 2008 How tumours escape mass destruction Oncogene. 27 45 5894 5903 1:CAS:528:DC%2BD1cXhtF2msbbJ 10.1038/onc.2008.268 18836470
14. AC Halpern LM Schuchter 1997 Prognostic models in melanoma Semin Oncol 24 1 Suppl 4 S2 S7 1:STN:280:DyaK2s3lt12huw%3D%3D 9122730
15. AJ Marrogi A Munshi AJ Merogi Y Ohadike A El-Habashi OL Marrogi, et al. 1997 Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma Int J Cancer 74 5 492 501 1:CAS:528:DyaK2sXmvFCls74%3D 10.1002/(SICI)1097-0215(19971021)74:5<492::AID- IJC3>3.0.CO;2-Z 9355970
16. Y Naito K Saito K Shiiba A Ohuchi K Saigenji H Nagura, et al. 1998 CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 16 3491 3494 1:CAS:528:DyaK1cXlsFajsb4%3D 9721846
17. O Nakano M Sato Y Naito K Suzuki S Orikasa M Aizawa, et al. 2001 Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity Cancer Res 61 13 5132 5136 1:CAS:528:DC%2BD3MXltVequ7Y%3D 11431351
18. S Vesalainen P Lipponen M Talja K Syrjanen 1994 Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma Eur J Cancer 30A 12 1797 1803 1:STN:280:DyaK2M7os1aguw%3D%3D 10.1016/0959-8049(94)E0159-2 7880609
19. MR Raspollini F Castiglione D Rossi Degl'innocenti G Amunni A Villanucci F Garbini, et al. 2005 Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma Ann Oncol 16 4 590 596 1:STN:280:DC%2BD2M7kvVWmsg%3D%3D 10.1093/annonc/mdi112 15699022
20. RD Dadmarz A Ordoubadi A Mixon CO Thompson KC Barracchini YM Hijazi, et al. 1996 Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion Canc J Sci Am 2 5 263 272 1:STN:280:DC%2BD28rnsFCgtQ%3D%3D
21. S Kooi HZ Zhang R Patenia CL Edwards CD Platsoucas RS Freedman 1996 HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2 Cell Immunol 174 2 116 128 1:CAS:528: DyaK28XnsF2itrY%3D 10.1006/cimm.1996.0301 8954611
22. AE Loercher MA Nash JJ Kavanagh CD Platsoucas RS Freedman 1999 Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells J Immunol. 163 11 6251 6260 1:CAS:528:DyaK1MXns12rtL8%3D 10570318
23. M Nakashima K Sonoda T Watanabe 1999 Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 Nat Med 5 8 938 942 1:CAS:528:DyaK1MXltVyjtr4%3D 10.1038/11383 10426319
24. H Rabinowich TE Reichert Y Kashii BR Gastman MC Bell TL Whiteside 1998 Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes J Clin Invest 101 11 2579 2588 1:CAS:528:DyaK1cXjvVahsLg%3D 10.1172/JCI1518 9616229
25. AD Santin S Bellone A Ravaggi S Pecorelli MJ Cannon GP Parham 2000 Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells Obstet Gynecol 96 3 422 430 1:CAS:528:DC%2BD3cXlvV2ns74%3D 10.1016/S0029-7844(00)00916-9 10960637
26. EY Woo CS Chu TJ Goletz K Schlienger H Yeh G Coukos, et al. 2001 Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res 61 12 4766 4772 1:CAS:528:DC%2BD3MXks1GrtbY%3D 11406550
27. A Mantovani P Allavena A Sica F Balkwill 2008 Cancer-related inflammation Nature 454 7203 436 444 1:CAS:528:DC%2BD1cXovV2mtbg%3D 10.1038/nature07205 18650914
28. BH Nelson 2008 The impact of T-cell immunity on ovarian cancer outcomes Immunol Rev 222 101 116 1:CAS:528:DC%2BD1cXlsFejtrs%3D 10.1111/j.1600-065X.2008. 00614.x 18363996
29. K Hayashi K Yonamine K Masuko-Hongo T Iida K Yamamoto K Nishioka, et al. 1999 Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans Gynecol Oncol 74 1 86 92 1:STN:280:DyaK1MzjtlOmuw%3D%3D 10.1006/gyno.1999.5430 10385556
30. RP Negus GW Stamp J Hadley FR Balkwill 1997 Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines Am J Pathol 150 5 1723 1734 1:STN:280: DyaK2s3ot12lsA%3D%3D 9137096
31. AD Santin PL Hermonat A Ravaggi S Bellone JJ Roman CV Smith, et al. 2001 Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer Gynecol Obstet Invest 51 4 254 261 1:STN:280:DC%2BD3MzksFeisA%3D%3D 10.1159/000058060 11408737
32. M Tomsova B Melichar I Sedlakova I Steiner 2008 Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma Gynecol Oncol 108 2 415 420 1:CAS:528:DC%2BD1cXhtlOqtb8%3D 10.1016/j.ygyno.2007.10.016 18037158
33. P Rolland I Spendlove Z Madjid EA Rakha P Patel IO Ellis, et al. 2007 The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer Int J Cancer 120 6 1311 1317 1:CAS:528:DC%2BD2sXhvVOju7g%3D 10.1002/ijc.22430 17187363
34. AP Vicari I Treilleux S Lebecque 2004 Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines Semin Cancer Biol 14 3 161 169 1:CAS:528:DC%2BD2cXjvVemsbw%3D 10.1016/j.semcancer.2003.10.002 15246051
35. TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram, et al. 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 9 942 949 1:CAS:528:DC%2BD2cXntFSkt7g%3D 10.1038/nm1093 15322536
36. MR Bernsen JH Diepstra P van Mil CJ Punt CG Figdor GN van Muijen, et al. 2004 Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells J Pathol 202 1 70 79 1:CAS:528:DC%2BD2cXnslCnsQ%3D%3D 10.1002/path.1494 14694523
37. M Haas A Dimmler W Hohenberger GG Grabenbauer G Niedobitek LV Distel 2009 Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia BMC Gastroenterol. 9 65 10.1186/1471-230X-9-65 19732435
38. Menetrier-Caux C, Gobert M, Caux C (2009) Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Canc Res
39. Y Mizukami K Kono Y Kawaguchi H Akaike K Kamimura H Sugai, et al. 2008 Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer Br J Cancer 98 1 148 153 1:CAS:528: DC%2BD1cXisF2rsg%3D%3D 10.1038/sj.bjc.6604149 18087278
40. N Leffers MJ Gooden RA de Jong BN Hoogeboom KA ten Hoor H Hollema, et al. 2009 Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer Cancer Immunol Immunother 58 3 449 459 10.1007/s00262-008-0583-5 18791714